Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Alia Al-Tayyib to Substance Abuse, Intravenous

This is a "connection" page, showing publications Alia Al-Tayyib has written about Substance Abuse, Intravenous.

 
Connection Strength
 
 
 
2.504
 
  1. Al-Tayyib A, Koester S, Langegger S, Raville L. Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern. Subst Use Misuse. 2017 07 03; 52(8):1051-1058.
    View in: PubMed
    Score: 0.484
  2. Al-Tayyib AA, Koester S, Riggs P. Prescription opioids prior to injection drug use: Comparisons and public health implications. Addict Behav. 2017 02; 65:224-228.
    View in: PubMed
    Score: 0.465
  3. Al-Tayyib AA, Thiede H, Burt RD, Koester S. Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009. Prev Sci. 2015 Feb; 16(2):330-40.
    View in: PubMed
    Score: 0.417
  4. Al-Tayyib AA, Rice E, Rhoades H, Riggs P. Association between prescription drug misuse and injection among runaway and homeless youth. Drug Alcohol Depend. 2014 Jan 01; 134:406-409.
    View in: PubMed
    Score: 0.383
  5. Al-Tayyib AA, Koester S. Injection drug users' experience with and attitudes toward methadone clinics in Denver, CO. J Subst Abuse Treat. 2011 Jul; 41(1):30-6.
    View in: PubMed
    Score: 0.318
  6. Nassau T, Al-Tayyib A, Robinson WT, Shinefeld J, Brady KA. The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015. Public Health Rep. 2020 Jul/Aug; 135(1_suppl):138S-148S.
    View in: PubMed
    Score: 0.152
  7. Abara WE, Trujillo L, Broz D, Finlayson T, Teshale E, Paz-Bailey G, Glick S, Al-Tayyib AA, Robinson WT, Masiello-Schuette S, Sey EK, Anderson BJ, Poe J, Braunstein S. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015. J Infect Dis. 2019 07 02; 220(3):377-385.
    View in: PubMed
    Score: 0.142
  8. Robinson WT, Kazbour C, Nassau T, Fisher K, Sheu S, Rivera AV, Al-Tayyib A, Glick SN, Braunstein S, Barak N, Shinefeld J, Poe J, Raymond HF, Brady K. Brief Report: Nonfatal Overdose Events Among Persons Who Inject Drugs: Findings From Seven National HIV Behavioral Surveillance Cities 2009 & 2012. J Acquir Immune Defic Syndr. 2017 07 01; 75 Suppl 3:S341-S345.
    View in: PubMed
    Score: 0.123
  9. Smith BD, Teshale E, Jewett A, Weinbaum CM, Neaigus A, Hagan H, Jenness SM, Melville SK, Burt R, Thiede H, Al-Tayyib A, Pannala PR, Miles IW, Oster AM, Smith A, Finlayson T, Bowles KE, Dinenno EA. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Clin Infect Dis. 2011 Oct; 53(8):780-6.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)